Explore health-genomics markers through a tier-graded evidence library that separates established findings from emerging research. New personalized-report and consultation intake is paused; join the waitlist for availability updates.
Every marker we surface carries an evidence tier: STRONG, VALIDATED, MODERATE, EMERGING, or EXPLORATORY. You see what’s clinically actionable today, what’s still under investigation, and where the boundary sits. No false certainty.
Our evidence library explains how published genomic findings are graded and why personal and family history matter when a qualified clinician interprets genetic data.
We connect marker context to questions people can bring to their existing healthcare providers, including when confirmatory testing may be worth discussing.
You see what is clinically actionable today, what is still under investigation, and where the boundary sits. No false certainty.
Direct-to-consumer (DTC) genetic testing provides a broad overview of your genomic profile, yet the clinical interpretation of these findings requires professional oversight. A genetic clinician contextualizes raw data within your personal and family medical history, distinguishing between benign variations and findings that necessitate clinical action.
Professional consultation can place results in context and reduce the risk of unnecessary anxiety or false reassurance from automated reports.
If a report identifies markers associated with hereditary conditions, such as predispositions for cardiovascular disease or oncological risks, clinical follow-up is essential. A qualified professional can determine if additional diagnostic-grade testing is required and assist in developing a proactive surveillance or management strategy tailored to your risk profile.
Heritable Health's evidence library connects marker context with questions worth discussing with a qualified clinician, drawing on current clinical standards and peer-reviewed genomic research.
If you have identified a marker of concern, discuss it with a qualified clinician who can review it alongside your personal and family history.
A curated selection from the marker library, with evidence tiers and linked references to help you prepare questions for a qualified clinician.
Join the waitlist for updates when personalized reports and video consultations accept new intake. The evidence library remains open while you wait.
ウェイトリストに参加するExplore the evidence library and note the markers you want to understand.
Join the waitlist for personalized-report and consultation availability updates.
If intake opens in your region, we will share the next steps before you provide DNA data.
テレジェノミクスは、遠隔医療を利用してゲノムサービスを提供します。これは、遺伝学者との相談を通じてあなたの遺伝データを解釈し、個別の健康推奨を提供することを含みます。
New consultation intake is paused. Join the waitlist for updates when availability changes.
New patient data sharing is paused. The evidence library is available without a DNA upload, and supported formats will be published before intake opens.
はい、私たちはあなたのプライバシーとデータのセキュリティを最優先にしています。すべてのDNAデータは安全に保存され、最大限の注意を払って取り扱われています。
Discuss it with your existing clinician, who may recommend diagnostic-grade follow-up testing. Availability, billing, and laboratory pathways depend on your country, region, and healthcare provider.
When intake is open, consultations are conducted through secure video calls for personalized, confidential discussions.
The human genome is comprised of approximately 3.2 billion base pairs, and because you inherit one copy from each parent, each of your cells carries about 6.4 billion in total. While the vast majority of our genetic sequence is identical across the species, roughly 10 million positions exhibit variation between individuals. These points of difference represent the biological diversity that influences everything from physical traits to disease susceptibility.
A single nucleotide polymorphism (SNP) is a variation at a specific position in the DNA sequence. As the most prevalent form of genetic variation, SNPs serve as critical biological markers. By identifying patterns in these variations, clinicians can map genetic predispositions and better understand the underlying mechanisms of various health conditions.
